Christopher Morrow
Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher Morrow as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:38 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07459959 · LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical ResponseJohns Hopkins University · not yet recruiting · Alzheimer s Disease · principal investigator
- Ph2NCT06604520 · Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaJohns Hopkins University · recruiting · Fronto-temporal Dementia, Fronto-temporal Lobar Dementia, Frontotemporal Degeneration · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Serotonin Modulation of Neural Circuitry in bvFTD: Understanding the Neurobiology of Mood and Cognitive SymptomsK23AG088248 · NIA · JOHNS HOPKINS UNIVERSITY · fiscal years 2024 to 2026 · $198,211 awarded in 2026Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:38 UTC. The ranking covers the 200 most relevant of 42 PubMed records, and a shared surname and initials can bring in a namesake. All 42 on PubMed
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.Gynecol Oncol · 19911,098 citationsRCR 38.9
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.J Clin Oncol · 1997508 citationsRCR 14.9
- 129 citationsRCR 4.2
- 127 citationsRCR 15.3
- Improving the detection and prediction of suicidal behavior among military personnel by measuring suicidal beliefs: an evaluation of the Suicide Cognitions Scale.J Affect Disord · 201489 citationsRCR 4.6
- 89 citationsRCR 3.3
- Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study.Am J Obstet Gynecol · 199987 citationsRCR 2.8
- Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial.J Acad Nutr Diet · 202084 citationsRCR 4.1
- 67 citationsRCR 6.7
- A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.Gynecol Oncol · 200066 citationsRCR 1.7